Home » Topics » Regulatory

Regulatory
RSS

FDA approves first medical therapy for endogenous Cushing's syndrome

Feb. 20, 2012

Health Canada approves line extension for Prevnar 13

Feb. 17, 2012

FDA approves new gel for male hypogonadism

Feb. 16, 2012

Line extension for Vyvanse in U.S.

Feb. 8, 2012

Japanese approval for new formulation of Fosrenol

Feb. 3, 2012

FDA approves ivacaftor for rare form of cystic fibrosis

Feb. 1, 2012

Jentadueto approved in U.S.

Jan. 31, 2012

FDA approves first treatment for advanced BCC

Jan. 31, 2012

FDA approves axitinib for advanced renal cell carcinoma

Jan. 30, 2012

Indication for Gadovist 1.0 is expanded

Jan. 30, 2012